• ADMA Biologics' (ADMA) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

    Source: Buzz FX / 04 Mar 2025 09:36:16   America/Chicago


    ADMA Biologics' (ADMA) "Overweight" Rating Reaffirmed at Cantor Fitzgerald Written by MarketBeat March 4, 2025 Share Link copied to clipboard. ADMA Biologics ( NASDAQ:ADMA - Get Free Report ) 's stock had its "overweight" rating reiterated
    Read more...
Share on,